| 摘要 |
<p>The invention provides a method for the diagnosis and treatment of neurological diseases or disorders characterized by disruption of the blood/brain barrier. The 92 kDa zymogen of gelatinase B and active gelatinase B are markers of neuropathologies associated with disruption of the blood/brain barrier.</p> |
